Serological surveillance of noroviruses in a community-based prospective cohort: a study protocol

• Published in: BMJ open 2021-03, Vol.11 (3), p.e043228-e043228
• Main Authors: Wang, Lu, Xie, Dongjie, Yu, Jingrong, Koroma, Mark Momoh, Qiu, Mengsi, Duan, Wentao, Zhang, Xu-Fu, Dai, Ying-Chun
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Age; Antibodies; Binding sites; Caliciviridae Infections - epidemiology; China - epidemiology; Disease Outbreaks; Epidemics; Epidemiology; Gender; Genomes; Genotype; Health surveillance; Herd immunity; Humans; Infectious Diseases; Laboratories; Molecular Epidemiology; Norovirus - genetics; Pandemics; Phylogeny; Population; Prospective Studies; Proteins; Public health; RNA polymerase; Seroepidemiologic Studies; Serology; Sociodemographics; Young Adult
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2020-043228

IntroductionNoroviruses are the leading cause of viral acute gastroenteritis affecting all age groups. Since 2014, the previous rarely reported GII.P17-GII.17 and recombinant GII.P16-GII.2 norovirus emerged, replacing GII.4 predominant genotype, causing increased outbreaks in China and other countries. Meanwhile, GII.4/2012 Sydney strain has re-emerged as the dominant variant in many places in 2015–2018. The role of herd immunity as the driving force during these new emerging or re-emerging noroviruses is poorly defined. Serological surveillance studies on community-based prospective cohort on norovirus are highly needed.Methods and analysesThis study will include 1000 out of 9798 participants aged 18 years and above from Caofeidian district, Tangshan city, northern China. Baseline data on sociodemographic characteristics and blood samples were collected in 2013–2014. Blood collection will be replicated annually throughout the cohort until 2023. Saliva samples were also collected in 2016. The seroprevalence and seroincidence of blockade antibodies against norovirus genotypes of GII.P17-GII.17, GII.P16-GII.2, the re-emerged GII.4/2012 and potential novel pandemic variants will be evaluated by ELISA. Associations between genotype blockade antibodies and sociodemographic factors and human histo-blood group antigens will be evaluated using univariate and multivariate analysis. The dynamics of herd immunity duration will be estimated in this longitudinal surveillance.Ethics and disseminationThe study has been approved by the Ethical Committees of the Staff Hospital of Jidong oil-field of China National Petroleum Corporation. This study will provide insight into the seroprevalence and seroincidence of noroviruses, and their relationships with sociodemographic characteristics and genetic susceptibility. It will also explain herd immunity of the emerged and re-emerged genotypes or variants. The study will further enable an understanding of the mechanism driving the replacement of norovirus genotypes. Research findings will be disseminated in peer-reviewed journals and at scientific meetings.